Yüklüyor......
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
Objectives: C1q is a valuable biomarker of disease activity in systemic lupus erythematosus (SLE). The “gold standard” assay, rocket immunoelectrophoresis (RIE), is time-consuming, and thus a shift to soluble immune precipitation techniques such as nephelometry has occurred. However, quantification...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357986/ https://ncbi.nlm.nih.gov/pubmed/30740097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00007 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|